New Strong Buy Stocks for October 7th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Alignment Healthcare, Inc. ALHC: This healthcare platform for seniors has seen the Zacks Consensus Estimate for its current year earnings increasing 14.3% over the last 60 days.
StoneCo Ltd. STNE: This fin-tech company that provides software solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 8.7% over the last 60 days.
eGain Corporation EGAN: This company that provides an AI-powered knowledge hub designed to automate and enhance customer experiences has seen the Zacks Consensus Estimate for its current year earnings increasing 52.2% over the last 60 days.
Phibro Animal Health Corporation PAHC: This animal health and mineral nutrition company has seen the Zacks Consensus Estimate for its current year earnings increasing 10% over the last 60 days.
MGIC Investment Corporation MTG: This mortgage insurance company has seen the Zacks Consensus Estimate for its current year earnings increasing 10.1% over the last 60 days.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MGIC Investment Corporation (MTG): Free Stock Analysis Report
eGain Corporation (EGAN): Free Stock Analysis Report
Phibro Animal Health Corporation (PAHC): Free Stock Analysis Report
StoneCo Ltd. (STNE): Free Stock Analysis Report
Alignment Healthcare, Inc. (ALHC): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Source Zacks-com


